Aging is the primary risk factor for Alzheimer's disease (AD), which is a rapidly growing public health concern. Understanding the mechanisms of normal brain aging may provide insight into the factors linking advancing age to increased risk for AD and thereby lead to new therapeutic targets for preventing or slowing AD progression. Cardiovascular changes, including impaired cerebrovascular function, occur with aging and may increase risk for AD; however, the mechanisms by which cerebrovascular function becomes impaired in older adults are incompletely understood. The overall goal of this project is to examine potential mechanisms of age-related declines in cerebrovascular function in humans. The investigators hypothesize that brain macro-vascular endothelial dysfunction, secondary to oxidative stress, plays an important role in mediating age-related changes in brain blood flow and cerebrovascular reactivity. The results of this pilot study have the potential to identify novel targets of cerebrovascular aging and will help guide the design of future clinical trials aimed at improving cerebral blood flow in older adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
34
Ascorbic acid will be infused into an antecubital vein using a IV infusion pump beginning with a priming bolus of 0.06 g Ascorbic Acid per kg fat-free mass dissolved in 100 ml of saline followed by a "drip-infusion" of 0.02 g Ascorbic Acid per kg fat-free mass dissolved in 30 ml of saline.
Normal saline will be infused by the research nurse into an antecubital vein using an IV infusion pump.
Neurovascular Aging Laboratory
Newark, Delaware, United States
Change from baseline in internal carotid artery (ICA) diameter after acute infusion of the antioxidant ascorbic acid
Cerebrovascular reactivity to hypercapnia
Time frame: Change from baseline to 30 minutes post-infusion
Change from baseline in middle cerebral artery (MCA) diameter after acute infusion of the antioxidant ascorbic acid
Cerebrovascular reactivity to hypercapnia
Time frame: Change from baseline to 30 minutes post-infusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.